Dirk Matthias Hermann

Summary

Country: Germany

Publications

  1. ncbi Implications of vascular endothelial growth factor for postischemic neurovascular remodeling
    Dirk Matthias Hermann
    Department of Neurology, University Hospital Essen, University of Duisburg Essen, Essen, Germany
    J Cereb Blood Flow Metab 29:1620-43. 2009
  2. ncbi Promoting brain remodelling and plasticity for stroke recovery: therapeutic promise and potential pitfalls of clinical translation
    Dirk M Hermann
    Department of Neurology, University Hospital Essen, Essen, Germany
    Lancet Neurol 11:369-80. 2012
  3. ncbi Enhancing the delivery of erythropoietin and its variants into the ischemic brain
    Dirk M Hermann
    Department of Neurology, University Hospital Essen, Germany
    ScientificWorldJournal 9:967-9. 2009
  4. ncbi Sleep-related breathing and sleep-wake disturbances in ischemic stroke
    Dirk M Hermann
    Department of Neurology, University Hospital Essen, Essen, Germany
    Neurology 73:1313-22. 2009
  5. ncbi Nonhematopoietic variants of erythropoietin in ischemic stroke: need for step-wise proof-of-concept studies
    Dirk M Hermann
    Department of Neurology, University Hospital Essen, Germany
    ScientificWorldJournal 10:2285-7. 2010
  6. ncbi Future Perspectives for Brain Pharmacotherapies: Implications of Drug Transport Processes at the Blood-brain Barrier
    Dirk M Hermann
    Chair of Vascular Neurology and Dementia, Department of Neurology, University Hospital Essen, Essen, Germany
    Ther Adv Neurol Disord 1:167-79. 2008
  7. ncbi Post-acute delivery of erythropoietin induces stroke recovery by promoting perilesional tissue remodelling and contralesional pyramidal tract plasticity
    Raluca Reitmeir
    Dementia and Ageing Disorders, Department of Neurology, University Hospital Essen, Hufelandstr 55, D 45122 Essen, Germany
    Brain 134:84-99. 2011
  8. ncbi ATP-binding cassette transporters at the blood-brain barrier in ischaemic stroke
    Pauline Patak
    Department of Neurology, University Hospital Essen, Germany
    Curr Pharm Des 17:2787-92. 2011
  9. ncbi Combination of tissue-plasminogen activator with erythropoietin induces blood-brain barrier permeability, extracellular matrix disaggregation, and DNA fragmentation after focal cerebral ischemia in mice
    Anil Zechariah
    Department of Neurology, University Hospital Essen, Hufelandstrasse 55, D 45122 Essen, Germany
    Stroke 41:1008-12. 2010

Collaborators

  • Claudio L Bassetti
  • Raluca Reitmeir
  • Pauline Patak
  • Ayman ElAli
  • Anil Zechariah
  • Ertugrul Kilic
  • Max Gassmann
  • Marco Bacigaluppi
  • Ulkan Kilic
  • Stefano Pluchino
  • Giuliana Salani

Detail Information

Publications9

  1. ncbi Implications of vascular endothelial growth factor for postischemic neurovascular remodeling
    Dirk Matthias Hermann
    Department of Neurology, University Hospital Essen, University of Duisburg Essen, Essen, Germany
    J Cereb Blood Flow Metab 29:1620-43. 2009
    ..Only on the basis of such information can more definite conclusions be made with regard to whether the translation of therapeutic angiogenesis into clinics is promising...
  2. ncbi Promoting brain remodelling and plasticity for stroke recovery: therapeutic promise and potential pitfalls of clinical translation
    Dirk M Hermann
    Department of Neurology, University Hospital Essen, Essen, Germany
    Lancet Neurol 11:369-80. 2012
    ..Balancing the opportunities and possible risks, we provide suggestions for the translation of restorative therapies from the laboratory to the clinic...
  3. ncbi Enhancing the delivery of erythropoietin and its variants into the ischemic brain
    Dirk M Hermann
    Department of Neurology, University Hospital Essen, Germany
    ScientificWorldJournal 9:967-9. 2009
    ....
  4. ncbi Sleep-related breathing and sleep-wake disturbances in ischemic stroke
    Dirk M Hermann
    Department of Neurology, University Hospital Essen, Essen, Germany
    Neurology 73:1313-22. 2009
    ..Sleep-related breathing disturbances (SDB) and sleep-wake disturbances (SWD) are often neglected in stroke patients. Recent studies suggest that they are frequent and have an impact on stroke outcome...
  5. ncbi Nonhematopoietic variants of erythropoietin in ischemic stroke: need for step-wise proof-of-concept studies
    Dirk M Hermann
    Department of Neurology, University Hospital Essen, Germany
    ScientificWorldJournal 10:2285-7. 2010
    ..Only with such information should decisions be made whether intranasal Neuro-EPO may be evaluated in human patients...
  6. ncbi Future Perspectives for Brain Pharmacotherapies: Implications of Drug Transport Processes at the Blood-brain Barrier
    Dirk M Hermann
    Chair of Vascular Neurology and Dementia, Department of Neurology, University Hospital Essen, Essen, Germany
    Ther Adv Neurol Disord 1:167-79. 2008
    ..As such, restorative and anti-inflammatory strategies acting at the blood-brain interface might gain therapeutic potential in the future...
  7. ncbi Post-acute delivery of erythropoietin induces stroke recovery by promoting perilesional tissue remodelling and contralesional pyramidal tract plasticity
    Raluca Reitmeir
    Dementia and Ageing Disorders, Department of Neurology, University Hospital Essen, Hufelandstr 55, D 45122 Essen, Germany
    Brain 134:84-99. 2011
    ..Our study establishes a plasticity-promoting effect of erythropoietin after stroke, indicating that erythropoietin acts via recruitment of contralesional rather than of ipsilesional pyramidal tract projections...
  8. ncbi ATP-binding cassette transporters at the blood-brain barrier in ischaemic stroke
    Pauline Patak
    Department of Neurology, University Hospital Essen, Germany
    Curr Pharm Des 17:2787-92. 2011
    ....
  9. ncbi Combination of tissue-plasminogen activator with erythropoietin induces blood-brain barrier permeability, extracellular matrix disaggregation, and DNA fragmentation after focal cerebral ischemia in mice
    Anil Zechariah
    Department of Neurology, University Hospital Essen, Hufelandstrasse 55, D 45122 Essen, Germany
    Stroke 41:1008-12. 2010
    ..The reasons for the adverse effects of EPO in t-PA-treated patients are unknown...